Data Insights
No filters selected
No filters selected
No filters selected
No filters selected
Melatonin by RepoCeuticals for Radiodermatitis: Likelihood of Approval
Melatonin is under clinical development by RepoCeuticals and currently in Phase II for Radiodermatitis. According to GlobalData, Phase II drugs...
Melatonin by RepoCeuticals for Actinic (Solar) Keratosis: Likelihood of Approval
Melatonin is under clinical development by RepoCeuticals and currently in Phase II for Actinic (Solar) Keratosis. According to GlobalData, Phase...
Melatonin by RepoCeuticals for Gastrointestinal Radiation Toxicity: Likelihood of Approval
Melatonin is under clinical development by RepoCeuticals and currently in Phase II for Gastrointestinal Radiation Toxicity. According to GlobalData, Phase...